Home Overview Press Room Blog Publications For Students about us
Search

About the States' Policies & Human Biotechnology


Individual states are filling the regulatory void created by the federal government’s failure to provide comprehensive legislation governing human biotechnologies. This is creating an often inconsistent policy patchwork.

California

State action is evident in a number of areas, including embryonic stem cell, cloning, egg retrieval, and assisted reproduction. More than a dozen states have laws banning reproductive cloning, about half of which also prohibit cloning for stem cell research. Dozens of similar bills are introduced in other states each year.

In response to President Bush’s restrictions on the federal funding of human embryonic stem cell research, several states initiated their own funded research programs. California led the way in 2004 with Proposition 71, which set aside $3 billion of public funds for stem cell research over ten years.



Cloning-Derived Stem Cells Raise Policy Questionsby Jessica CussinsBiopolitical TimesMay 16th, 2013Yesterday’s announcement that stem cells have been derived from cloned human embryos set off a media flurry, but important questions about reproductive cloning and women’s health were not widely addressed.
Branstad Signs Bill Widening DNA Sampling to Misdemeanor CasesAssociated PressMay 16th, 2013People convicted of certain aggravated misdemeanors in Iowa now will be required to submit DNA samples to the federal DNA database.
Cloning, Stem Cells Long Mired In Legislative Gridlock[Quotes CGS's Marcy Darnovsky]by Julie RovnerNPRMay 16th, 2013The news that U.S. scientists have successfully cloned a human embryo seems almost certain to rekindle a political fight that has raged, on and off, since the announcement of the creation of Dolly the sheep in 1997.
The DNA in Your Garbage: Up For Grabsby Kevin HartnettThe Boston GlobeMay 12th, 2013Drop a hair? Anyone can legally sequence your genetic material—and privacy experts want to close that gap.
Made-to-Order Embryos: You Want to Sell What?!by Jessica CussinsBiopolitical TimesMay 2nd, 2013The fact that a fertility clinic can own and sell made-to-order embryos for profit raises novel concerns that should not be collapsed into predefined frameworks used to assess other assisted reproductive technologies.
Wake Forest examines eugenics here and abroadby John HintonWinston-Salem JournalApril 2nd, 2013A conference examines the history of forced sterilization in North Carolina and Central Europe, and the legacies of eugenics.
Surrogate Offered $10,000 to Abort Babyby Elizabeth CohenCNNMarch 6th, 2013A surrogate refused to have an abortion after severe abnormalities were spotted on an ultrasound and moved to Michigan, where she became the legal mother.
Should Patients Understand that They are Research Subjects? by Jenny ReardonSan Francisco ChronicleMarch 3rd, 2013A routine form at a UCSF doctor's appointment stipulates that your tissues and cells can be collected, and that you have no rights to any "commercially useful products that may be developed."
Stem Cells in Texas: Cowboy Cultureby David CyranoskiNatureFebruary 13th, 2013By offering unproven therapies, a Texas biotechnology firm has sparked a bitter debate about how stem cells should be regulated.
Yes, Virginia, Your Reproductive Rights Are Compromised by Alex SternHuffington PostFebruary 12th, 2013In Virginia as in many other states, legislative battles about reproductive rights are front and center. One pending bill proposes reparations for victims of the state's eugenic sterilization policy; the other seeks to end the 30-day waiting period for sterilization.
Displaying 1-10 of 270  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760